Review
Accepted on 17 Oct 2024
The possibility of off-label uses of β-blockers and statins in the breast, colorectal, prostate and lung cancers: an update
in Experimental Pharmacology and Drug Discovery
Review
Accepted on 17 Oct 2024
in Experimental Pharmacology and Drug Discovery
Original Research
Accepted on 17 Oct 2024
in Breast Cancer
Brief Research Report
Accepted on 17 Oct 2024
in Neuropharmacology
Original Research
Published on 17 Oct 2024
in Cognitive Neuroscience
Review
Published on 17 Oct 2024
in Sleep Disorders
Original Research
Published on 17 Oct 2024
in Physical Oceanography
Original Research
Published on 17 Oct 2024
in Occupational Health and Safety
Original Research
Published on 17 Oct 2024
in Non-Neuronal Cells
Perspective
Published on 17 Oct 2024
in Positive Psychology
Original Research
Published on 17 Oct 2024
in Health Economics
Original Research
Published on 17 Oct 2024
in Pediatric Hematology and Hematological Malignancies
Original Research
Published on 17 Oct 2024
in Social Physics
Original Research
Published on 17 Oct 2024
in AI in Business
Original Research
Published on 17 Oct 2024
in Molecular and Cellular Oncology
Original Research
Published on 17 Oct 2024
in Aging and the Immune System
Correction
Published on 17 Oct 2024
in Multiple Sclerosis and Neuroimmunology